Find clinical trials for Non-Small-Cell Lung Cancer in Pittsburgh, PA

with zimberelimab, and domvanalimab in combination with zimberelimab and etrumadenant (AB928) in front-line, PD-L1 positive, metastatic non- ...

This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non...

PDCT in participants with previously untreated Stage IV or recurrent non-small cell lung cancer (NSCLC)....

This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemothe...

This is an open-label, multicenter, non-randomized, Phase 2 study to determine the safety, tolerability and efficacy of encorafenib given in-...

to determine the efficacy and safety of durvalumab and/or novel oncology therapies, with or without chemotherapy, for first-line Stage IV Non...

This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that over...

and atezolizumab in the first line treatment of metastatic non-squamous NSCLC patients with asymptomatic untreated brain metastases....

alone for the treatment of locally advanced or metastatic non-small cell lung cancer. Some lung ...

This is a Phase I open label multi-center study to evaluate the safety, tolerability, pharmacokinetics and preliminary effectiveness of the investiga...